Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helicobacter Pylori Eradication According to DPO-PCR Methods: Duration of Triple Therapy and Bismuth Quadruple According to Clarithromycin Resistance Patterns (K-CREATE Study)

NCT04147065 is registered in ClinicalTrials.gov with Incheon St.Mary's Hospital as lead sponsor.

NCT NCT04147065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helicobacter Pylori Eradication According to DPO-PCR Methods: Duration of Triple Therapy and Bismuth Quadruple According to Clarithromycin Resistance Patterns (K-CREATE Study)
Lead sponsor
Incheon St.Mary's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 14, 2021
Completion date
March 30, 2025
Enrollment
1,230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection